Company intelligence / Profile preview

Scion Enterprises

New York, NY, United Statesfacebook.com ↗

Ownership: Private
Development stage: Other

Overview

Scion Life Sciences is a New York City-based venture capital firm dedicated to founding and building biotechnology companies that develop clinically transformational or curative new medicines. They provide long-term capital and operational resources to support their portfolio from early incubation through IPO/commercialization. Their inaugural fund closed at $310 million in February 2024. Clinical results are dependent on individual portfolio companies; no direct clinical data for Scion itself.

Therapeutic areas: OtherRare Diseases
Industry: Investors

Partnerships

Not specifically disclosed; collaborates with academic/industry partners for innovation sourcing.Petrichor is noted as a key affiliate/partner.

Beyond the preview

Go deeper on Scion Enterprises.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scion Enterprises.

Explore the full profile